One-year safety and efficacy of ustekinumab and results of dose adjustment after switching from inadequate methotrexate treatment: the TRANSIT randomized trial in moderate-to-severe plaque psoriasis

K Reich, L Puig, C Paul, K Kragballe, T Luger, J Lambert, S Chimenti, G Girolomoni, J-F Nicolas, E Rizova, M Brunori, S Mistry, P Bergmans, J Barker, TRANSIT Investigators, Anthony Ormerod

Research output: Contribution to journalArticlepeer-review

30 Citations (Scopus)

Fingerprint Dive into the research topics of 'One-year safety and efficacy of ustekinumab and results of dose adjustment after switching from inadequate methotrexate treatment: the TRANSIT randomized trial in moderate-to-severe plaque psoriasis'. Together they form a unique fingerprint.

Medicine & Life Sciences